131 related articles for article (PubMed ID: 7318160)
1. Bronchoalveolar macrophages in sarcoidosis and cryptogenic fibrosing alveolitis.
du Bois RM; Townsend PJ; Cole PJ; Haslam PL; Turner-Warwick M
Clin Allergy; 1981 Sep; 11(5):409-19. PubMed ID: 7318160
[TBL] [Abstract][Full Text] [Related]
2. Alveolar macrophage lysosomal enzyme and C3b receptors in cryptogenic fibrosing alveolitis.
du Bois RM; Townsend PJ; Cole PJ
Clin Exp Immunol; 1980 Apr; 40(1):60-5. PubMed ID: 7389217
[TBL] [Abstract][Full Text] [Related]
3. Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis.
Haslam PL; Parker DJ; Townsend PJ
Chest; 1990 Mar; 97(3):651-61. PubMed ID: 2306967
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic analysis of alveolar macrophages in normal subjects and in patients with interstitial lung disease.
Campbell DA; Poulter LW; Du Bois RM
Thorax; 1986 Jun; 41(6):429-34. PubMed ID: 3787519
[TBL] [Abstract][Full Text] [Related]
5. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis.
Hance AJ; Basset F; Saumon G; Danel C; Valeyre D; Battesti JP; Chrétien J; Georges R
Ann N Y Acad Sci; 1986; 465():643-56. PubMed ID: 3488004
[TBL] [Abstract][Full Text] [Related]
6. [Macrophage-lymphocyte alveolitis in pulmonary sarcoidosis. The role of T-lymphocytes and alveolar macrophages in the pathogenesis and monitoring of this disease].
Rossi GA; Vassalo F; Sacco O; Cerri E; Degl'Innocenti L
Rev Mal Respir; 1988; 5(5):511-8. PubMed ID: 3055098
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid.
Costabel U; Bross KJ; Andreesen R; Matthys H
Thorax; 1986 Apr; 41(4):261-5. PubMed ID: 3461577
[TBL] [Abstract][Full Text] [Related]
8. Comparison of alveolar macrophage and blood monocyte oxidative burst response in pulmonary sarcoidosis.
Nielsen H; Frederiksen J; Sherson D; Milman N
APMIS; 1990 May; 98(5):401-6. PubMed ID: 2162680
[TBL] [Abstract][Full Text] [Related]
9. Value of enumerating cellular constituents of bronchoalveolar lavage fluid in differentiating sarcoidosis and cryptogenic fibrosing alveolitis.
Pande JN; Sharma SK; Verma K
Sarcoidosis; 1990 Sep; 7(2):96-100. PubMed ID: 2255801
[TBL] [Abstract][Full Text] [Related]
10. [Bronchoalveolar lavage in cryptogenic fibrosing alveolitis and sarcoidosis].
Velenská Z; Dobiás J
Cas Lek Cesk; 1986 Jul; 125(29):895-7. PubMed ID: 3731227
[No Abstract] [Full Text] [Related]
11. Angiotensin-converting enzyme in serum and in bronchoalveolar lavage in sarcoidosis.
Gupta RG; Sicilian L; Catchatourian R; Bekerman C; Oparil S; Szidon JP
Respiration; 1982; 43(3):153-7. PubMed ID: 6287548
[TBL] [Abstract][Full Text] [Related]
12. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases.
Nagai S; Aung H; Takeuchi M; Kusume K; Izumi T
Chest; 1991 Mar; 99(3):674-80. PubMed ID: 1995225
[TBL] [Abstract][Full Text] [Related]
13. Mast cell and histamine content of human bronchoalveolar lavage fluid.
Agius RM; Godfrey RC; Holgate ST
Thorax; 1985 Oct; 40(10):760-7. PubMed ID: 4060097
[TBL] [Abstract][Full Text] [Related]
14. The morphogenesis and classification of diffuse interstitial lung diseases: a clinicopathological approach, based on tissue reaction patterns.
Henderson DW
Aust N Z J Med; 1984 Oct; 14(5 Suppl 3):735-48. PubMed ID: 6598040
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis.
Pantelidis P; Southcott AM; Black CM; Du Bois RM
Clin Exp Immunol; 1997 Apr; 108(1):95-104. PubMed ID: 9097917
[TBL] [Abstract][Full Text] [Related]
16. Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis.
Gallagher RB; Guckian M; van Breda A; Odlum C; Fitzgerald MX; Feighery C
Eur Respir J; 1988 Feb; 1(2):153-60. PubMed ID: 2966072
[TBL] [Abstract][Full Text] [Related]
17. Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease.
Robinson BW
Thorax; 1988 Jul; 43(7):508-15. PubMed ID: 3212749
[TBL] [Abstract][Full Text] [Related]
18. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis.
Pueringer RJ; Schwartz DA; Dayton CS; Gilbert SR; Hunninghake GW
Chest; 1993 Mar; 103(3):832-8. PubMed ID: 8449077
[TBL] [Abstract][Full Text] [Related]
19. Proliferating alveolar macrophages in BAL and lung function changes in interstitial lung disease.
Pforte A; Gerth C; Voss A; Beer B; Häussinger K; Jütting U; Burger G; Ziegler-Heitbrock HW
Eur Respir J; 1993 Jul; 6(7):951-5. PubMed ID: 8370443
[TBL] [Abstract][Full Text] [Related]
20. Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease.
Hoogsteden HC; van Dongen JJ; van Hal PT; Delahaye M; Hop W; Hilvering C
Chest; 1989 Mar; 95(3):574-7. PubMed ID: 2920586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
